ELOXX PHARMACEUTICALS, INC. Income Taxes Paid
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Income Taxes Paid of $2.00 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2022-03-30
- ELOXX PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2020-12-31 was $0.00.
- ELOXX PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2020-09-30 was $0.00.
- ELOXX PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2019-12-31 was -$43.00K.
- ELOXX PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2019-09-30 was $0.00.
- ELOXX PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2020 was $5.00K, a 86.11% decline from fiscal 2019.
- ELOXX PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2019 was $36.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2021-06-30 | $2.00K 10-Q · filed 2021-08-16 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $5.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $5.00K 10-Q · filed 2020-11-06 | ||
| 2020-06-30 | $5.00K 10-Q · filed 2021-08-16 | |||
| 2019-12-31 | -$43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$43.00K derived: sum of 2 quarters · filed 2022-03-30 | $36.00K 10-K · filed 2022-03-30 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $79.00K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $79.00K 10-Q · filed 2020-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |